Advisor Group Holdings, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,106 shares of MIRM stock, worth $79,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,106
Previous 806
37.22%
Holding current value
$79,355
Previous $41,000
36.59%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding MIRM
# of Institutions
230Shares Held
56.1MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$488 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$376 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$232 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$198 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$189 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...